Skip to main content

previous disabled Page of 20
and
  1. No Access

    Article

    Assessing the Benefits and Harms of Pharmacotherapy in Older Adults with Frailty: Insights from Pharmacoepidemiologic Studies of Routine Health Care Data

    The objective of this review is to summarize and appraise the research methodology, emerging findings, and future directions in pharmacoepidemiologic studies assessing the benefits and harms of pharmacotherapi...

    Dae Hyun Kim, Chan Mi Park, Darae Ko, Kueiyu Joshua Lin, Robert J. Glynn in Drugs & Aging (2024)

  2. Article

    Open Access

    PCSK9 Inhibitors and Infection-Related Adverse Events: A Pharmacovigilance Study Using the World Health Organization VigiBase

    Protein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) are novel lipid-lowering agents used in patients with cardiovascular disease. Despite reassuring safety data from pivotal trials, increasing evide...

    Dahyun Park, Sungho Bea, Ji-Hwan Bae, Hyesung Lee in Drugs - Real World Outcomes (2024)

  3. Article

    Open Access

    Angiotensin Receptor Blockers and the Risk of Suspected Drug-Induced Liver Injury: A Retrospective Cohort Study Using Electronic Health Record-Based Common Data Model in South Korea

    Angiotensin receptor blockers are widely used antihypertensive drugs in South Korea. In 2021, the Korea Ministry of Food and Drug Safety acknowledged the need for national compensation for a drug-induced liver...

    Hyunjoo Kim, Nayeong Son, Dahee Jeong, Myungsik Yoo, In Young Choi in Drug Safety (2024)

  4. Article

    Open Access

    Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-administration of Four Individual Components in Healthy Participants

    This study aimed to assess and compare the pharmacokinetics, safety, and tolerability of a fixed-dose combination product (FDCP) comprising four different drugs (two antihypertensive drugs, amlodipine and losa...

    **-Woo Park, Hyewon Chung, Jong-Min Kim, Na Young Kim, Sung Hee Hong in Drugs in R&D (2024)

  5. No Access

    Article

    Comparative Genitourinary Safety of In-class Sodium-Glucose Cotransporter-2 Inhibitors among Patients with Heart Failure with Preserved Ejection Fraction: A Cohort Study

    The American Heart Association recommended sodium-glucose cotransporter-2 inhibitors (SGLT2i) for the management of heart failure with preserved ejection fraction (HFpEF). However, little is known about their ...

    Munaza Riaz, **gchuan Guo, Steven M. Smith in American Journal of Cardiovascular Drugs (2024)

  6. No Access

    Article

    Exploring the effect of BRCA1/2 status on chemotherapy-induced hematologic toxicity in patients with ovarian cancer

    BRCA1/2 are integral to the DNA repair mechanism and their germline pathogenic variants (gBRCA) result in a high risk for develo** breast and ovarian cancer. Patients with gBRCA mutations showed increased sensi...

    In Hee Lee, Soo Jung Lee, Juhyung Kim, Yoon Hee Lee in Cancer Chemotherapy and Pharmacology (2024)

  7. No Access

    Article

    Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea

    The DAPA-HF and DELIVER trials demonstrated the clinical benefits of dapagliflozin in heart failure (HF) patients across the entire ejection fraction (EF) spectrum. However, further investigation is needed for...

    Eui-Soon Kim, Sun-Kyeong Park in American Journal of Cardiovascular Drugs (2024)

  8. Article

    Open Access

    Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases

    SB5 is an approved biosimilar of adalimumab, a recombinant monoclonal anti-tumor necrosis factor (TNF) antibody. The approval of SB5 was based on the comparison with reference adalimumab in analytical studies,...

    Jonathan Kay, Raymond K. Cross Jr, Steven R. Feldman, Youn** Park in Advances in Therapy (2024)

  9. No Access

    Article

    Validation of a Natural Language Machine Learning Model for Safety Literature Surveillance

    As part of routine safety surveillance, thousands of articles of potential interest are manually triaged for review by safety surveillance teams. This manual triage task is an interesting candidate for automat...

    Jiyoon Park, Malek Djelassi, Daniel Chima, Robert Hernandez in Drug Safety (2024)

  10. No Access

    Article

    Matching-Adjusted Indirect Comparisons of Brexucabtagene Autoleucel with Alternative Standard Therapies for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Adult Patients

    Brexucabtagene autoleucel (brexu-cel), a CD19-directed chimeric antigen receptor T-cell therapy, is approved for relapsed/refractory B-cell precursor acute lymphoblastic leukemia in adults aged 18+/26+ years i...

    Bijal Shah, Jenny M. H. Chen, James J. Wu, Chaoling Feng, Lang Zhou in Advances in Therapy (2023)

  11. Article

    Open Access

    Real-World Use, Safety, and Patient Experience of 20% Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases

    The CORE study aimed to provide a detailed understanding of real-world immune globulin subcutaneous (human) 20% solution (Ig20Gly) utilization in patients with primary immunodeficiency diseases (PIDs) in Germa...

    Maria Fasshauer, Michael Borte, Michaela Bitzenhofer in Advances in Therapy (2023)

  12. Article

    Open Access

    In-Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period

    SB12 is a biosimilar to eculizumab reference product [SolirisTM (Soliris is a trademark of Alexion Pharmaceuticals, Inc.)] that acts as a C5 complement protein inhibitor. The infusion stability of in-use (diluted...

    Minji Tak, Hawon Jeong, Jihoon Yun, Jihyun Kim, Soyeon Kim, Yoonsook Lee in Drugs in R&D (2023)

  13. Article

    Open Access

    Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors

    Patients with hypertension and additional cardiovascular risk factors pose a challenge by requiring more intensive blood pressure (BP) control. Single-pill combination (SPC) therapy can benefit these patients ...

    Jaewon Oh, Wonho Kim, Gee-Hee Kim, Hack-Lyoung Kim, Sang-Don Park in Advances in Therapy (2023)

  14. No Access

    Article

    Clinical implications and chemo-sensitivity of adjuvant chemotherapy in patients with poorly cohesive cells-gastric cancer

    Poorly cohesive cells-gastric cancer (PCC-GC) represents distinct features within the GC spectrum. The present study investigated the clinicopathologic characteristics and chemo-sensitivity for a relatively la...

    ** Ho Baek, Byung Woog Kang, Hyojeung Kang in Cancer Chemotherapy and Pharmacology (2023)

  15. Article

    Open Access

    Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel

    Trastuzumab deruxtecan (T-DXd)—an antibody–drug conjugate targeting the human epidermal growth factor receptor 2 (HER2)—improved outcomes of patients with HER2-positive and HER2-low metastatic breast cancer. G...

    Joanne Wing Yan Chiu, Soo Chin Lee, James Chung-man Ho, Yeon Hee Park in Drug Safety (2023)

  16. No Access

    Article

    Does Opioid Use Disorder Matter for Health Care Utilization Among Lung Cancer Patients? Evidence from U.S. Hospitals During 2016–2020

    The number of hospitalizations due to opioid use disorders in the USA increased steadily from 62,010 in 1998–2000 to 136,240 in 2015–2016; however, no health care utilization of lung cancer patients with opioi...

    Jeong-Hui Park, Sun Jung Kim, Lily Grajeda, Alexiya Ramirez in Clinical Drug Investigation (2023)

  17. Article

    Open Access

    Effect of on-site first aid for industrial injuries on healthcare utilization after medical treatment: a 4-year retrospective longitudinal study

    The number of industrially injured workers (IIW) is increasing in Korea. However, little research has been conducted on whether first aid is performed at industrial sites or on the association between first ai...

    **hyun Kim, Hyunkyu Kim, Eun-Cheol Park in Journal of Occupational Medicine and Toxic… (2023)

  18. No Access

    Article

    Development and Application of an Active Pharmacovigilance Framework Based on Electronic Healthcare Records from Multiple Centers in Korea

    With the availability of retrospective pharmacovigilance data, the common data model (CDM) has been identified as an efficient approach towards anonymized multicenter analysis; however, the establishment of a ...

    Seon Choe, Suhyun Lee, Chan Hee Park, Jeong Hoon Lee, Hyo Jung Kim in Drug Safety (2023)

  19. No Access

    Article

    Systematic Review of the Economic Evaluation of Sodium–Glucose Cotransporter-2 Inhibitors Used as Treatment in Patients with Heart Failure

    Sodium–glucose cotransporter-2 (SGLT2) inhibitors have been recently used as therapeutic agents for type 2 diabetes mellitus. Recent clinical trials have shown that they are beneficial for reducing the risk of...

    Kyungae Nam, Daniel Sung-Ho Cho, Hyunji Kim, Byung** Kwon in Clinical Drug Investigation (2023)

  20. Article

    Open Access

    Preliminary feasibility of integrating tobacco treatment into SUD peer recovery coaching: a mixed-methods study of peer recovery coaches

    Individuals with substance use disorder (SUD) have high prevalence of cigarette smoking and difficulty quitting. Peer recovery coaches (PRCs; individuals with lived SUD experience) facilitate SUD behavior chan...

    Joanna M. Streck, Susan Regan, Michael Werner in Addiction Science & Clinical Practice (2023)

previous disabled Page of 20